Authors:
BERESFORD IJM
SHELDRICK RLG
BALL DI
TURPIN MP
WALSH DM
HAWCOCK AB
COLEMAN RA
HAGAN RM
TYERS MB
Citation: Ijm. Beresford et al., GR159897, A POTENT NONPEPTIDE ANTAGONIST AT TACHYKININ NK2 RECEPTORS, European journal of pharmacology, 272(2-3), 1995, pp. 241-248
Authors:
CLITHEROW JW
SCOPES DIC
SKINGLE M
JORDAN CC
FENIUK W
CAMPBELL IB
CARTER MC
COLLINGTON EW
CONNOR HE
HIGGINS GA
BEATTIE D
KELLY HA
MITCHELL WL
OXFORD AW
WADSWORTH AH
TYERS MB
Citation: Jw. Clitherow et al., EVOLUTION OF A NOVEL SERIES OF [(N,N-DIMETHYLAMINO)PROPYL]ANILIDE ANDPIPERAZINYLBENZANILIDES AS THE FIRST SELECTIVE 5-HT1D ANTAGONISTS, Journal of medicinal chemistry, 37(15), 1994, pp. 2253-2257
Citation: Rm. Hagan et al., INTERACTIONS BETWEEN 5-HT(3) RECEPTORS AND CEREBRAL DOPAMINE FUNCTION- IMPLICATIONS FOR THE TREATMENT OF SCHIZOPHRENIA AND PSYCHOACTIVE SUBSTANCE-ABUSE, Psychopharmacology, 112(1), 1993, pp. 190000068-190000075
Citation: Sc. Stratton et al., ANXIOLYTIC ACTIVITY OF TACHYKININ NK2, RECEPTOR ANTAGONISTS IN THE MOUSE LIGHT-DARK BOX, European journal of pharmacology, 250(3), 1993, pp. 180000011-180000012
Authors:
SKINGLE M
SCOPES DIC
FENIUK W
CONNOR HE
CARTER MC
CLITHEROW JW
TYERS MB
Citation: M. Skingle et al., GR127935 - A POTENT ORALLY-ACTIVE 5-HT(1D) RECEPTOR ANTAGONIST, British Journal of Pharmacology, 110, 1993, pp. 160000009-160000009
Authors:
SMITH AG
DOMENEY AM
COSTALL B
NAYLOR RJ
TYERS MB
Citation: Ag. Smith et al., ALOSETRON ATTENUATES REBOUND HYPERACTIVITY INDUCED BY WITHDRAWAL FROMA CHRONIC MESOLIMBIC DOPAMINE INFUSION AND SYSTEMIC NEUROLEPTIC TREATMENT, British Journal of Pharmacology, 110, 1993, pp. 160000100-160000100